Antibiotics for Streptococcus agalactiae (Group B Streptococcus)
Penicillin G is the first-line antibiotic for treating Streptococcus agalactiae infections due to its narrow spectrum of activity, proven efficacy, and the fact that no resistance has been documented. 1
First-line Treatment Options
For Non-Allergic Patients:
- Penicillin G: 5 million units IV initial dose, then 2.5 million units IV every 4 hours until delivery/resolution (for intrapartum prophylaxis or treatment) 2
- Ampicillin: 2 g IV initial dose, then 1 g IV every 4 hours (alternative to penicillin) 2
- Amoxicillin: 500 mg orally three times daily for 10 days (for less severe infections) 3
For Penicillin-Allergic Patients:
Non-anaphylactic allergy:
- Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours 2
Anaphylactic allergy (with susceptibility testing available):
Anaphylactic allergy (without susceptibility testing or resistant strains):
Antimicrobial Resistance Considerations
It's important to note that while S. agalactiae remains universally susceptible to penicillin and other β-lactams, resistance to alternative antibiotics is increasing:
- Recent studies show high resistance rates to erythromycin (29-46%) and clindamycin (47-63%) 5
- A 2023 study from China found that all tested S. agalactiae strains remained susceptible to penicillin, ampicillin, linezolid, vancomycin, tigecycline, and quinupristin-dalfopristin 6
Clinical Scenarios
Invasive Infections (Meningitis, Endocarditis)
For severe invasive infections like meningitis or endocarditis:
- First-line: Penicillin G at high doses 1
- Alternative: Vancomycin 15-20 mg/kg/dose IV every 8-12 hours 2
- Some experts recommend adding rifampin to vancomycin for meningitis cases 2
Intrapartum Prophylaxis
For preventing neonatal GBS disease:
- First-line: Penicillin G 5 million units IV initial dose, then 2.5 million units IV every 4 hours until delivery 2
- Alternative: Ampicillin 2 g IV initial dose, then 1 g IV every 4 hours until delivery 2
Eradication of Carriage
For eradicating GBS colonization in healthcare workers or high-risk individuals:
- Oral penicillin: 500 mg four times daily for 10 days 2
- Amoxicillin: 500 mg three times daily for 10 days 2
- Clindamycin: 300-500 mg four times daily for 10 days 2
- Azithromycin: 500 mg once daily for 3-5 days 2
Important Clinical Pearls
Universal susceptibility: S. agalactiae remains universally susceptible to penicillin, making it the drug of choice for all infections 6
Resistance testing: For penicillin-allergic patients, susceptibility testing for clindamycin and erythromycin should be performed when possible due to increasing resistance rates 2, 5
Combination therapy: For severe invasive infections like meningitis, some experts recommend combination therapy (e.g., vancomycin plus rifampin) 2
Duration of therapy: Treatment duration should be based on clinical response and infection site:
- Uncomplicated infections: 7-14 days
- Invasive infections (meningitis, endocarditis): 2-4 weeks
Common pitfall: Relying on erythromycin or clindamycin empirically without susceptibility testing in penicillin-allergic patients may lead to treatment failure due to increasing resistance rates 5